RESOLUTION 
Expressing support for the designation of November 2021 
as ‘‘Pancreatic Cancer Awareness Month’’. 
Whereas pancreatic cancer will kill an estimated 48,220 peo-
ple in the United States in 2021; 
Whereas pancreatic cancer is the third leading cause of can-
cer-related death in the United States; 
Whereas, in 2020 and 2021, pancreatic cancer has killed 
three American icons—Congressman John Lewis, Con-
gressman Alcee Hastings, and Supreme Court Justice 
Ruth Bader Ginsburg; 
16:36 Nov 15, 2021
HR790
2 
•HRES 790 IH 
Whereas an additional 60,430 individuals in the United 
States will be diagnosed with pancreatic cancer in 2021; 
Whereas of those diagnosed with pancreatic cancer, 72 per-
cent will die within the first year of their diagnosis; 
Whereas persistent health care inequities and disparities for 
communities of color compound the devastation of pan-
creatic cancer; 
Whereas the incidence rate for pancreatic cancer among 
Black Americans is 20 percent higher than that of any 
other racial demographic; 
Whereas the pancreatic cancer death rate is 17 percent high-
er for Black men than for White men; 
Whereas the lack of pancreatic cancer early detection re-
search accelerates the racial unfairness in the United 
States health care system, with devastating consequences 
for minorities; 
Whereas pancreatic cancer has no early detection test to di-
agnose this cancer quickly and accurately determine the 
presence of this cancer; 
Whereas, if diagnosed early, the 5-year survival rate for pan-
creatic cancer patients is above 80 percent; 
Whereas if pancreatic cancer is detected late, the 5-year sur-
vival rate drops to less than 10 percent; 
Whereas without adequate funding and early detection re-
search, pancreatic cancer is not discovered until the late 
stages of this horrific cancer where treatment options are 
limited; 
Whereas in fiscal year 2020, pancreatic cancer received its 
own dedicated research program at the Department of 
16:36 Nov 15, 2021
HR790
3 
•HRES 790 IH 
Defense under the Congressionally Directed Medical Re-
search Programs; 
Whereas in the Department of Defense Appropriations Act, 
2020 (division A of Public Law 116–93), Congress ap-
propriated funds to the Congressionally Directed Medical 
Research Programs, with $6,000,000 going to the Pan-
creatic Cancer Research Program; 
Whereas during the consideration of H.R. 6395 (the National 
Defense Authorization Act for Fiscal Year 2021), the 
House of Representatives agreed to an amendment to the 
bill that was filed with the Committee on Rules by Rep-
resentative Carson of Indiana to increase the authoriza-
tion of funds by $5,000,000 for pancreatic cancer re-
search, including an early detection initiative, by the De-
partment of Defense, and the House of Representatives 
passed the bill with that amendment included; 
Whereas during the consideration of H.R. 4350 (the National 
Defense Authorization Act for Fiscal Year 2022), the 
House of Representatives agreed to an amendment to the 
bill that was filed with the Committee on Rules by Rep-
resentative Carson, Representative Eshoo, and Rep-
resentative McKinley to increase the authorization of 
funds by $5,000,000 for pancreatic cancer research, in-
cluding an early detection initiative, by the Department 
of Defense, and the House of Representatives passed the 
bill with that amendment included; 
Whereas during the consideration of H.R. 7617 (the Defense, 
Commerce, Justice, Science, Energy and Water Develop-
ment, Financial Services and General Government, 
Homeland Security, Labor, Health and Human Services, 
Education, Transportation, Housing, and Urban Develop-
ment Appropriations Act, 2021), the House of Represent-
16:36 Nov 15, 2021
HR790
4 
•HRES 790 IH 
atives agreed to an amendment to the bill that was filed 
with the Committee on Rules by Representative Carson 
of Indiana and Representative Eshoo to increase the 
amount appropriated for a pancreatic cancer early detec-
tion initiative from $10,000,000 to $15,000,000, and the 
House of Representatives passed the bill with that 
amendment included; and 
Whereas the 117th Congress has a unique opportunity to 
make a historic investment in pancreatic cancer research 
at the Department of Defense: Now, therefore, be it 
Resolved, That the House of Representatives— 
1
(1) supports the designation of ‘‘Pancreatic 
2
Cancer Awareness Month’’; 
3
(2) recognizes the critical importance of in-
4
creasing funding for pancreatic cancer research at 
5
the Department of Defense and the National Insti-
6
tutes of Health to find effective treatments for this 
7
cancer and reduce the disproportionate impact on 
8
communities of color; and 
9
(3) supports the efforts of the many advocacy 
10
organizations to educate communities in the United 
11
States about pancreatic cancer and the need for 
12
more research funding, early detection initiatives, di-
13
agnostic tests, and effective treatments. 
14
Æ 
16:36 Nov 15, 2021
HR790
